Nuo Therapeutics, Inc. (AURX): Capital Expenditures
$274.8K
Year ended 2025-12-31
$297.1K
Trailing 12 months to 2026-06-30
+66.1%
3-year compound annual growth
-8.9%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $274.8K | +77.3% | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | $155.0K | n/m | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | $7.2K | -87.9% | 2025-04-01, From 2023-01-01 |
| 2022-12-31 | $60.0K | n/a | 2024-04-19, From 2022-01-01 |
| 2021-12-31 | $0 | n/a | 2023-04-17, From 2021-01-01 |
| 2020-12-31 | $0 | n/a | 2022-04-15, From 2020-01-01 |
| 2019-12-31 | $0 | n/a | 2022-04-15, From 2019-01-01 |
| No annual figure between 2015-12-31 and 2019-12-31. | |||
| 2015-12-31 | $698.2K | +44.6% | 2016-10-24, From 2015-01-01 |
| 2014-12-31 | $483.0K | -35.7% | 2016-10-24, From 2014-01-01 |
| 2013-12-31 | $750.7K | n/a | 2015-03-31, From 2013-01-01 |
| No annual figure between 2011-12-31 and 2013-12-31. | |||
| 2011-12-31 | $66.4K | -91.4% | 2012-03-29, From 2011-01-01 |
| 2010-12-31 | $774.6K | n/a | 2012-03-29, From 2010-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Nuo Therapeutics, Inc. (AURX) | 2025-12-31 | $274.8K | +77.3% |
| IceCure Medical Ltd. (ICCM) | 2025-12-31 | $36.0K | -49.3% |
| Tenon Medical, Inc. (TNON) | 2025-12-31 | $273.0K | +46.8% |
| Intelligent Bio Solutions Inc. (INBS) | 2026-06-30 | $125.7K | -45.8% |
| Lucid Diagnostics Inc. (LUCD) | 2025-12-31 | $197.0K | -33.4% |
| Femasys Inc (FEMY) | 2025-12-31 | $525.0K | -31.1% |
| Cerenome, Inc. (CNSY) | 2025-12-31 | $67.0K | -54.1% |
| Vycor Medical Inc (VYCO) | 2025-12-31 | $5.2K | -2.6% |
| EBR Systems, Inc. (NONE.) | 2025-12-31 | $3.68M | n/m |
Compare AURX, ICCM, TNON, INBS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗